Our co-hosts interview Dr. Amanda Nickles Fader on the recently present results of NRG-GY019.

Our co-hosts discuss the NRG-BR009 'OFSET' study for premenopausal ER-positive/HER2-negative breast cancer patients that have a high risk of cancer returning with study team members Dr. Shannon Puhalla and Dr. Sandra Swain. Also on this episode, we interview Dr. Haane Massarotti on her own experience facing breast cancer as a young adult.

American Medical Association President, Dr. Bobby Mukkamala, discusses how his personal experiences in his cancer journey impact his outlook and goals in his AMA Presidency & Dr. James Yu discusses his experiences using patient-reported outcomes from clinical research to help guide health policy.

Our co-hosts interview NRG-HN009 PI Dr. Paul Harari on the recently reported initial results of NRG-HN009 at the 2026 Multidisciplary Head and Neck Cancer Symposium. Additionally, this episode discusses NRG-HN010 for HER2-expressing salivary gland cancer with Study PI, Dr. Alan Ho.

Our co-hosts discuss who the NRG Protocol Operations Management "POM" Committee is and what they are responsible for with outgoing Chair, Dr. Maria Werner-Wasik and incoming Chair, Dr. Alexandra Thomas.

In the first half of this episode, our co-hosts interview NRG Oncology Sarcoma Subcommittee Chairs, Dr. Dian Wang and Dr. William Tseng on the priorities and goals of the newer subcommittee within NRG's organization.

In the second half, our co-hosts meet with MLB Player Chris Taylor and his wife Mary Taylor, the co-founders of the CT3 Foundation to discuss how sarcoma has touched their lives and fueled their passion to move the needle in sarcoma research.

This episode features our first ever guest co-host and former NRG Oncology Group Chair, Dr. Wally Curran.

JAMA Editor in Cheif, Dr. Kirsten Bibbins-Domingo discusses JAMA and the JAMA Network and the process for selection and publication of manuscripts.

We take a look at the barriers faced by smaller institutions and rural institutions with Dr. Naoto Ueno of the University of Hawaii in a two-episode series on small vs. larger institution challenges.

Today for Veteran's Day, we discuss the NRG Veteran Affairs and Military Treatment Facility Subcommittee and NCTN trials in the VA system with Subcommittee Chair, Dr. Vlad Sandulache.

For Pancreatic Cancer Awareness Month, we discuss the recently activated NRG-GI011 "LAP100" study for locally advanced pancreas cancer with study PI, Dr. Sanford.